| 51 |
33205006 | Gb3-cSrc complex in glycosphingolipid-enriched microdomains contributes to the expression of p53 mutant protein and cancer drug resistance via β-catenin-activated RNA methylation. | 2020 Nov |
1 |
| 52 |
33425912 | EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-κB/MDM2/p53 Pathway. | 2020 |
4 |
| 53 |
30254375 | TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer. | 2019 Jul |
1 |
| 54 |
30387173 | P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1. | 2019 Apr |
2 |
| 55 |
30591552 | Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression. | 2019 Feb 15 |
2 |
| 56 |
30622244 | Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells. | 2019 Jan 8 |
1 |
| 57 |
30656973 | MDM2 antagonist-loaded targeted micelles in combination with doxorubicin: effective synergism against human glioblastoma via p53 re-activation. | 2019 Jun - Jul |
1 |
| 58 |
30666159 | Peptidylarginine deiminase 4 overexpression resensitizes MCF-7/ADR breast cancer cells to adriamycin via GSK3β/p53 activation. | 2019 |
1 |
| 59 |
30667081 | Targeting mutant TP53 as a potential therapeutic strategy for the treatment of osteosarcoma. | 2019 Mar |
1 |
| 60 |
30678901 | Synthesis and evaluation of the antiproliferative efficacy of BRM270 phytocomposite nanoparticles against human hepatoma cancer cell lines. | 2019 Apr |
1 |
| 61 |
30683849 | SETD3 is a positive regulator of DNA-damage-induced apoptosis. | 2019 Jan 25 |
1 |
| 62 |
30728290 | Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity. | 2019 Feb 6 |
1 |
| 63 |
30760381 | PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer. | 2019 Feb |
1 |
| 64 |
30778138 | On-chip combined radiotherapy and chemotherapy testing on soft-tissue sarcoma spheroids to study cell death using flow cytometry and clonogenic assay. | 2019 Feb 18 |
1 |
| 65 |
30868056 | Histone deacetylase 2 is involved in DNA damage-mediated cell death of human osteosarcoma cells through stimulation of the ATM/p53 pathway. | 2019 Mar |
2 |
| 66 |
30883017 | Delanzomib, a novel proteasome inhibitor, sensitizes breast cancer cells to doxorubicin-induced apoptosis. | 2019 Apr |
1 |
| 67 |
30960044 | A Polycationic Brush Mediated Co-Delivery of Doxorubicin and Gene for Combination Therapy. | 2019 Jan 3 |
3 |
| 68 |
30971831 | Metformin prevention of doxorubicin resistance in MCF-7 and MDA-MB-231 involves oxidative stress generation and modulation of cell adaptation genes. | 2019 Apr 10 |
2 |
| 69 |
31022952 | p53-Dependent Apoptotic Effect of Puromycin via Binding of Ribosomal Protein L5 and L11 to MDM2 and its Combination Effect with RITA or Doxorubicin. | 2019 Apr 24 |
2 |
| 70 |
31081062 | INKA2, a novel p53 target that interacts with the serine/threonine kinase PAK4. | 2019 Jun |
1 |
| 71 |
31183995 | Modulated electro-hyperthermia induced p53 driven apoptosis and cell cycle arrest additively support doxorubicin chemotherapy of colorectal cancer in vitro. | 2019 Aug |
1 |
| 72 |
31231550 | Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity. | 2019 |
2 |
| 73 |
31235998 | MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells. | 2019 Jun 14 |
2 |
| 74 |
31244936 | Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma. | 2019 |
2 |
| 75 |
31319070 | Nicorandil prevents doxorubicin-induced human umbilical vein endothelial cell apoptosis. | 2019 Sep 15 |
1 |
| 76 |
31340166 | Doxorubicin and liposomal doxorubicin induce senescence by enhancing nuclear factor kappa B and mitochondrial membrane potential. | 2019 Sep 1 |
1 |
| 77 |
31346036 | Abrogation of FBW7α-dependent p53 degradation enhances p53's function as a tumor suppressor. | 2019 Sep 6 |
1 |
| 78 |
31366086 | Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation. | 2019 Jul 30 |
2 |
| 79 |
31417274 | Long noncoding RNA LINC-PINT promotes proliferation through EZH2 and predicts poor prognosis in clear cell renal cell carcinoma. | 2019 |
2 |
| 80 |
31480541 | DMPK is a New Candidate Mediator of Tumor Suppressor p53-Dependent Cell Death. | 2019 Sep 1 |
2 |
| 81 |
31482012 | Transcription-independent and -dependent p53-mediated apoptosis in response to genotoxic and non-genotoxic stress. | 2019 |
6 |
| 82 |
31488712 | p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities. | 2019 Sep 24 |
1 |
| 83 |
31497354 | Wild-type TP53 defined gamma-secretase inhibitor sensitivity and synergistic activity with doxorubicin in GSCs. | 2019 |
3 |
| 84 |
31503014 | Antitumor effect of a short peptide on p53-null SKOV3 ovarian cancer cells. | 2019 Nov |
1 |
| 85 |
31511498 | Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response. | 2019 Sep 11 |
1 |
| 86 |
31527453 | Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells. | 2019 Sep 16 |
1 |
| 87 |
31571866 | Tuning the surface coating of IONs toward efficient sonochemical tethering and sustained liberation of topoisomerase II poisons. | 2019 |
1 |
| 88 |
31871844 | Significance of TP53 mutation in bladder cancer disease progression and drug selection. | 2019 |
1 |
| 89 |
31976328 | Dihydroartemisinin Sensitizes Mutant p53 (R248Q)-Expressing Hepatocellular Carcinoma Cells to Doxorubicin by Inhibiting P-gp Expression. | 2019 |
8 |
| 90 |
32123852 | Aspirin ameliorates the long-term adverse effects of doxorubicin through suppression of cellular senescence. | 2019 Sep |
1 |
| 91 |
28797827 | Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through decreased expressions of p53/p21/p16. | 2018 Aug |
2 |
| 92 |
29207086 | Tan IIA inhibits H1299 cell viability through the MDM4‑IAP3 signaling pathway. | 2018 Feb |
2 |
| 93 |
29207090 | Long intergenic non‑coding RNA‑p21 mediates cardiac senescence via the Wnt/β‑catenin signaling pathway in doxorubicin-induced cardiotoxicity. | 2018 Feb |
1 |
| 94 |
29290620 | Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis. | 2018 Feb |
2 |
| 95 |
29352261 | Insight into the role of PIKK family members and NF-кB in DNAdamage-induced senescence and senescence-associated secretory phenotype of colon cancer cells. | 2018 Jan 19 |
3 |
| 96 |
29416744 | Experimental evidence of good efficacy and reduced toxicity with peptide-doxorubicin to treat gastric cancer. | 2018 Jan 5 |
1 |
| 97 |
29731965 | TP53 and OSBPL10 alterations in diffuse large B-cell lymphoma: prognostic markers identified via exome analysis of cases with extreme prognosis. | 2018 Apr 13 |
2 |
| 98 |
29743236 | IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53. | 2018 Jun 22 |
1 |
| 99 |
29772519 | p53 and P-glycoprotein influence chemoresistance in hepatocellular carcinoma. | 2018 Jun 1 |
1 |
| 100 |
29775409 | Transactivation domain of p53 regulates DNA repair and integrity in human iPS cells. | 2018 Sep 1 |
4 |